Combining Next-Generation Sequencing and Immune Assays: A Novel Method for Identification of Antigen-Specific T Cells
Authors:
Open Access
- 19 September 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (9) , e74231
Abstract
In this study, we combined a novel sequencing method, which can identify individual clonotypes based on their unique T cell receptor (TCR) rearrangement, with existing immune assays to characterize antigen-specific T cell responses. We validated this approach using three types of assays routinely used to measure antigen-specific responses: pentamers which enable identification of T cells bearing specific TCRs, activation marker expression following antigen stimulation and antigen-induced proliferation to identify cytomegalovirus (CMV) specific clonotypes. In one individual, 8 clonotypes were identified using a pentamer reagent derived from the CMV pp65 protein. The same 8 clonotypes were also identified following sequencing of cells that upregulated an activation marker following incubation with an identical peptide derived from pp65. These 8 and an additional 8 clonotypes were identified using a more sensitive CFSE-based proliferation assay. We found clear sequence homology among some of the clonotypes identified, and the CDR3 region in one clonotype was identical to a previously published pp65-specific clonotype sequence. Many of these CMV-specific clonotypes were present at frequencies below 10−5 which are undetectable using standard flow-cytometric methods. These studies suggest that an immune response is comprised of a diverse set of clones, many of which are present at very low frequencies. Thus, the combination of immune assays and sequencing depicts the richness and diversity of an immune response at a level that is not possible using standard immune assays alone. The methods articulated in this work provide an enhanced understanding of T cell-mediated immune responses at the clonal level.Keywords
This publication has 33 references indexed in Scilit:
- Novel cancer immunotherapy agents with survival benefit: recent successes and next stepsNature Reviews Cancer, 2011
- Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypesGenome Research, 2011
- A model for harmonizing flow cytometry in clinical trialsNature Immunology, 2010
- Response definition criteria for ELISPOT assays revisitedCancer Immunology, Immunotherapy, 2010
- Allergen‐specific T cell responses to immunotherapy monitored by CD154 and intracellular cytokine expressionClinical & Experimental Allergy, 2010
- Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencingGenome Research, 2009
- Measuring Antigen‐Specific Immune Responses, 2008 updateCytometry Part A, 2008
- Use of CD137 to study the full repertoire of CD8+ T cells without the need to know epitope specificitiesCytometry Part A, 2008
- Distinct sets of αβ TCRs confer similar recognition of tumor antigen NY-ESO-1157–165by interacting with its central Met/Trp residuesProceedings of the National Academy of Sciences, 2008
- Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencingProceedings of the National Academy of Sciences, 2008